The appropriate use of proton pump inhibitors (PPIs): need for a reappraisal

V Savarino, P Dulbecco, N de Bortoli… - European journal of …, 2017 - Elsevier
The advent of powerful acid-suppressive drugs, such as proton pump inhibitors (PPIs), has
revolutionized the management of acid-related diseases and has minimized the role of …

ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA …

Writing Committee Members, NS Abraham, MA Hlatky… - Circulation, 2010 - Am Heart Assoc
To avoid actual, potential, or perceived conflicts of interest that may arise as a result of
industry relationships or personal interests among the writing committee, all members of the …

Control of gastric acid secretion in health and disease

ML Schubert, DA Peura - Gastroenterology, 2008 - Elsevier
Recent milestones in the understanding of gastric acid secretion and treatment of acid-
peptic disorders include the (1) discovery of histamine H2-receptors and development of …

Interchangeable use of proton pump inhibitors based on relative potency

DY Graham, A Tansel - Clinical Gastroenterology and Hepatology, 2018 - Elsevier
Although proton pump inhibitors (PPIs) are widely used, their relative potency and ideal
dosing regimens remain unclear. We analyzed data from randomized clinical trials that …

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs

ND Yeomans, Z Tulassay, L Juhász… - … England Journal of …, 1998 - Mass Medical Soc
Background Suppressing acid secretion is thought to reduce the risk of ulcers associated
with regular use of nonsteroidal antiinflammatory drugs (NSAIDs), but the best means of …

Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome

MM Wolfe, G Sachs - Gastroenterology, 2000 - gastrojournal.org
One of the hallmarks of the mammalian stomach is its ability to secrete large quantities of
concentrated (0.16 mol/L) hydrochloric acid (HCl). 1 Although it is generally assumed that …

potassium‐competitive acid blockers for the treatment of acid‐related disorders

Y Abdel‐Aziz, DC Metz… - Alimentary Pharmacology …, 2021 - Wiley Online Library
Background Potassium‐competitive acid blockers (P‐CABs) are a novel group of acid‐
suppressing medicines for the management of acid‐related disorders. Aims To review …

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

EAJ Rauws, GNJ Tytgat - The Lancet, 1990 - Elsevier
Abstract 50 patients with intractable duodenal ulcer were randomly assigned to 4 weeks of
treatment with colloidal bismuth subcitrate (CBS) alone (26 patients) or with amoxicillin and …

Is there an optimal degree of acid suppression for healing of duodenal ulcers?: a model of the relationship between ulcer healing and acid suppression

DW Burget, SG Chiverton, RH Hunt - Gastroenterology, 1990 - Elsevier
The optimal degree and duration of suppression of gastric acidity required for the healing of
peptic ulcers has never been established. Although very potent inhibitors of acid secretion …

Pantoprazole: a review of its pharmacological properties and therapeutic use in acid-related disorders

A Fitton, L Wiseman - Drugs, 1996 - Springer
Pantoprazole | Drugs Skip to main content SpringerLink Account Menu Find a journal Publish
with us Track your research Search Cart 1.Home 2.Drugs 3.Article Pantoprazole A Review of its …